Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1355 of 6351
-
New device aims to spare rectal cancer patients from stoma surgery
Disease control Recruiting nowThe purpose of this clinical investigation is to evaluate the safety of the ColoSeal ICD System by evaluating its effectiveness in reducing the stoma creation rate and by comparing the rate of major complications to current standard of care for rectal cancer surgery with a divert…
Sponsor: Averto Medical, Inc. • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
Could a single iron infusion help heart failure patients feel better?
Symptom relief By invitation onlyThis study will investigate whether intravenous (IV) iron improves symptoms, exercise capacity, and quality of life in patients with heart failure with preserved ejection fraction (HFpEF) and iron deficiency. Iron deficiency is common in heart failure and is associated with wors…
Phase 2 • Sponsor: Government of Jersey • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Robot-Assisted surgery trial aims to ease swelling in head and neck lymphedema
Disease control Recruiting nowThe objective of this study is to evaluate the Symani System's safety and effectiveness for microsurgical anastomosis during open lymphatic reconstruction in the head and neck.
Sponsor: MMI (Medical Microinstruments, Inc.) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
AI could spot hidden prostate cancers missed by standard biopsies
Diagnosis Recruiting nowUse of AI algorithm for PCa detection is feasible, and AI-informed biopsies (AI-targeted and perilesional biopsy) improves csPCa detection in patients with indeterminate MRI lesions and in patients with low-risk MRI lesions and high-risk clinical features.
Sponsor: University of Arkansas • Aim: Diagnosis
Last updated Aug 21, 2026 00:00 UTC
-
Tiny wireless sensors could free fragile preemies from a tangle of wires
Knowledge-focused Recruiting nowA wireless and miniaturized vital sign (ECG, SpO2, Skin Temperature) sensor system, MicroPremVitals Button Sensors was developed by the Dr. John Rogers Laboratory (QSIB- Northwestern University, Chicago, USA) to facilitate vital sign monitoring in extremely preterm neonates.
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Can adjusting guselkumab doses tame tough Crohn's cases?
Disease control Recruiting nowCrohn's disease (CD) is a chronic and destructive inflammatory disease of the gastrointestinal tract characterized by phases of relapse and remission. Tumor necrosis factor (TNF) antagonists, anti-integrins and anti-interleukin (IL) 12/23 are the main therapeutic agents to obtain…
Phase 4 • Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug aims to shield kidneys during heart surgery
Prevention Not yet recruitingThis clinical study investigates the safety and potential effectiveness of the investigational drug SP16 in preventing acute kidney injury in patients with pre-existing chronic kidney disease who are undergoing cardiac surgery involving the use of cardiopulmonary bypass (heart-lu…
Phase 2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Prevention
Last updated Jun 27, 2026 14:02 UTC
-
New drug CAN016 takes on advanced cancers in first human trial
Disease control Recruiting nowA Phase I/II, Open-Label, Non-Randomized, Multi-Centre First-in-Human Study of CAN016 in Patients with Advanced Solid Tumors
Phase 1/2 • Sponsor: Canwell Biotech Limited • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Could a botox-like injection quiet shaky hands?
Symptom relief Recruiting nowUpper limb essential tremor (UL ET) is a movement disorder characterized by postural and/or kinetic tremor. It can cause difficulty with everyday tasks such as writing, pouring, and eating. This study will assess if AGN-151607-DP is safe and effective by assessing adverse events …
Phase 2 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
Does a common pain drug carry hidden abuse risk?
Knowledge-focused CompletedThe purpose of the present study is to assess prospectively the abuse potential of gabapentin compared to placebo and alprazolam in healthy non-drug-dependent recreational sedative drug users under fasted condition.
Phase 4 • Sponsor: Viatris Inc. • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
One-Stop shop: new study tests dual procedure for AFib patients
Disease control Recruiting nowThe OPTION-EMEA post-market study is intended to gather real world clinical data for patients undergoing AF ablation with the FARAPULSE™ Pulsed Field Ablation (PFA) System and subsequent left atrial appendage closure (LAAC) with a WATCHMAN FLX™ Pro or WATCHMAN FLX device during o…
Sponsor: Boston Scientific Corporation • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Could waiting to lower blood sugar after severe stroke improve outcomes?
Disease control Recruiting nowThis study is a exploratory, randomized, controlled, open-label, blinded-endpoint Phase II clinical trial designed to evaluate whether delaying antihyperglycemic treatment for 72 hours improves neurological outcomes in patients with severe stroke and hyperglycemia. A total of 42…
Phase 2 • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for myelofibrosis patients: experimental drug TQ05105 enters phase 2 trial
Disease control Recruiting nowThis is an open-label, single-arm, multi-center phase II study consisting of two cohorts. Cohort 1 evaluates the pharmacokinetics (PK) of TQ05105 in myelofibrosis participants with normal, mild, or moderate renal impairment to guide dosing. Cohort 2 evaluates the efficacy and saf…
Phase 2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for thalassemia: drug trial targets anemia without transfusions
Disease control Not yet recruitingThis study is a multicenter study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of treatment with SNH-119014 in adult participants with non-transfusion-dependent thalassemia. 30 participants with non-transfusion-dependent thalassemia were enrolled.
Phase 2 • Sponsor: ScinnoHub Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Common diabetes drug may slow rare abdominal cancer
Disease control Recruiting nowThis is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendiceal mucinous neoplasms (AMNs).
Phase 2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Stool test may predict gut healing in ulcerative colitis
Knowledge-focused By invitation onlyThis is a national prospective, multicenter, observational study. A total of 200 eligible patients will be enrolled from 10 hospitals across the country. Inclusion criteria are as follows: aged ≥ 18 years; diagnosed with moderate-to-severe active ulcerative colitis (UC); disease …
Sponsor: Tang-Du Hospital • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC
-
Can a smart glucose monitor keep diabetics out of the hospital?
Disease control Not yet recruitingAmong the diffident groups of patients, those with chronic and severe medical conditions are more likely to be readmitted to the hospital. It is not surprising therefore that patients with diabetes have high readmission rates. Patients with diabetes have 40% higher re-hospitaliza…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Vaccinia virus targets rectal tumors in new immunotherapy combo
Disease control Recruiting nowA Phase I clinical trial that will investigate the safety and tolerability of combining the modified vaccinia virus BT-001 with systemic pembrolizumab in patients with localised pMMR rectal cancer
Phase 1 • Sponsor: Henry Smith • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Balloon vs. stent: new trial could change how we treat blocked arteries
Disease control Recruiting nowThe main objective of this randomized, multicenter, international, open-label clinical trial is to demonstrate that, in the context of percutaneous coronary intervention for complex coronary artery disease, a SeQuent® SCB interventional strategy is non-inferior to a new-generatio…
Sponsor: B. Braun Melsungen AG • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Could exercise replace the scalpel for shoulder arthritis?
Disease control By invitation onlyArthritis of the shoulder glenohumeral joint is a growing problem in an aging population. Treatment options for glenohumeral arthritis can be grouped into three main categories: 1) shoulder replacement surgery, 2) injections (corticosteroid, hyaluronic acid and PRP) and physical …
Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC